Join to View Full Profile
1 Medical Center Dr"# Dhmc"Lebanon, NH 03756
Phone+1 603-650-7211
Are you Dr. Marotti?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jonathan Marotti, MD is a board certified pathologist in Lebanon, New Hampshire. He is currently licensed to practice medicine in New Hampshire, Vermont, and Massachusetts. He is an Assistant Professor at Geisel School of Medicine.
Education & Training
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Cytopathology, 2010 - 2011
Beth Israel Deaconess Medical Center/Harvard Medical School Breast PathologyFellowship, Selective Pathology, 2009 - 2010- Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Pathology-Anatomic and Clinical, 2005 - 2009
Geisel School of Medicine at DartmouthClass of 2005
Geisel School of Medicine at DartmouthClass of 2005
Certifications & Licensure
VT State Medical License 2013 - 2026
NH State Medical License 2011 - 2025
MA State Medical License 2007 - 2013
American Board of Pathology Pathology - Anatomic/Pathology - Clinical- American Board of Pathology Cytopathology
Publications & Presentations
PubMed
- Extensive epigenomic dysregulation is a hallmark of homologous recombination deficiency in triple-negative breast cancer.Youdinghuan Chen, Lucas A Salas, Jonathan D Marotti, Nicole P Jenkins, Chao Cheng
International Journal of Cancer. 2025-03-15 - Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy-Tolerant Persister Cells in ER+ Breast Cancer.Steven Tau, Mary D Chamberlin, Huijuan Yang, Jonathan D Marotti, Patricia C Muskus
Cancer Research. 2025-03-14 - Integrative co-registration of elemental imaging and histopathology for enhanced spatial multimodal analysis of tissue sections through TRACE.Yunrui Lu, Serin Han, Aruesha Srivastava, Neha Shaik, Matthew Chan
Bioinformatics Advances. 2025-01-01
Press Mentions
Dartmouth Investigators Study Impact of Shift in Testing Guidelines for Assessing HER2 Status in Breast Cancer PatientsFebruary 12th, 2016
